Jin, H. Y., Sharman, J., Laurenti, L., Ferrant, E., Montero, L. F. C., Mulligan, S., Harrup, R., Opat, S., Ibatici, A., Marasca, R., Sportoletti, P., Egginton, A., Thadani-Mulero, M., Cazarez, O., Jiang, Y., Boyer, M., Morschhauser, F. (2025). Long-term immune reconstitution and final 1-year follow-up after fixed-duration venetoclax-obinutuzumab (VenO) in first-line (1L) chronic lymphocytic leukemia (CLL): Results from the Phase III CRISTALLO trial. Blood. https://doi.org/10.1182/blood-2025-682